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Abstract
Background: Granzyme B is a serine protease which cleaves at unique tetrapeptide sequences. It is involved in
several signaling cross-talks with caspases and functions as a pivotal mediator in a broad range of cellular
processes such as apoptosis and inflammation. The granzyme B degradome constitutes proteins from a myriad of
functional classes with many more expected to be discovered. However, the experimental discovery and validation
of bona fide granzyme B substrates require time consuming and laborious efforts. As such, computational methods
for the prediction of substrates would be immensely helpful.
Results: We have compiled a dataset of 580 experimentally verified granzyme B cleavage sites and found
distinctive patterns of residue conservation and position-specific residue propensities which could be useful for in
silico prediction using machine learning algorithms. We trained a series of support vector machines (SVM) classifiers
employing Bayes Feature Extraction to predict cleavage sites using sequence windows of diverse lengths and
compositions. The SVM classifiers achieved accuracy and AROC scores between 71.00% to 86.50% and 0.78 to 0.94
respectively on independent test sets. We have applied our prediction method on the Chikungunya viral proteome
and identified several regulatory domains of viral proteins to be potential sites of granzyme B cleavage, suggesting
direct antiviral activity of granzyme B during host-viral innate immune responses.
Conclusions: We have compiled a comprehensive dataset of granzyme B cleavage sites and developed an
accurate SVM-based prediction method utilizing Bayes Feature Extraction to identify novel substrates of granzyme
B in silico. The prediction server is available online, together with reference datasets and supplementary materials.
Background
Proteolysis - the specific and limited cleavage of proteins
by enzymes called proteases - represents an important
mechanism for post-translational control in all living
organisms [1]. Granzymes (short for granule enzymes)
belong to a unique class of serine proteases which are
known to mediate critical roles in the innate immune
response against virus-infected or tumor cells through
the induction of apoptotic cell death [2]. Consequently,
the enzymes have been implicated in the pathogenesis
of several chronic inflammatory and cardiovascular dis-
orders. Granzymes are released into the cytoplasm of
the target cells through endocytosis of cytolytic granules
released by cytotoxic T cells or natural killer cells [2].
Once released into the target cells, granzymes go on to
cleave specific cellular proteins and activate multiple sig-
naling pathways leading to apoptotic cell death. Of the
five human subtypes discovered to date (granzymes A,
B, H, K and M), granzyme B has been the most well
studied. Like caspases, granzyme B recognizes specific
tetrapeptide sequence motifs (P4-P3-P2-P1)a n dc l e a v e
proteins after aspartate residue at P1 [3,4]. Besides cleav-
ing specific proteins regulating apoptotic cell death,
granzyme B has been reported to cleave proteins across
a wide spectrum of other functional classes, ranging
from nuclear and cytoskeletal components to membrane
receptors and viral proteins [5].
To date, more than 500 granzyme B substrates have
been characterized and many more are expected to be
identified [5]. While systematic experimental discovery
* Correspondence: lawrence@bic.nus.edu.sg
1Data Mining Department, Institute for Infocomm Research, 1 Fusionopolis
Way, #21-01 Connexis South Tower, Singapore 138632
Full list of author information is available at the end of the article
Wee et al. BMC Genomics 2011, 12(Suppl 3):S11
http://www.biomedcentral.com/1471-2164/12/S3/S11
© 2011 Wee et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.and validation of bona fide substrates are necessary for
elucidating the granzyme B degradome, many of the
processes are often time consuming and laborious. For
these reasons, computational prediction of substrates
could be immensely helpful in generating initial hypoth-
eses and experimental leads. While a wide range of
computational methods have been applied for substrate
prediction of related proteases such as caspases [6,7],
only a limited number are available for prediction of
granzyme B substrates. PeptideCutter [8] is a general
protease substrates cleavage prediction server which pre-
dicts for potential granyzme B cleavage sites using pre-
ferential tetrapeptide cleavage (P4-P3-P2-P1) specificities
derived from in vitro combinatorial library studies by
Thornberry et al. [4]. Backes et al. developed the GraB-
Cas software which extended the use of the in vitro spe-
cificities by incorporating position-specific scoring
matrices and accounting for conserved residues at P1’
and P2’ positions [9]. More recently, Barkan et al.
advanced the field through the application of the sup-
port vector machines (SVM) method on a set of experi-
mentally verified cleavage sites using both sequence and
structural features [10].
In this paper, we have compiled a dataset of 580
experimentally verified granzyme B cleavage sites and
found distinctive patterns of residue conservation and
position-specific residue propensities which could be
useful for in silico prediction using machine learning
algorithms. We trained a series of SVM classifiers
employing Bayes Feature Extraction to predict cleavage
sites using sequence windows of diverse lengths and
compositions. The SVM classifiers achieved accuracy
and AROC scores between 71.00% to 86.50% and 0.78 to
0.94 respectively on independent test sets. We applied
our prediction method on the Chikungunya viral pro-
teome and identified several regulatory domains of viral
proteins to be potential sites of granzyme B cleavage,
suggesting direct antiviral activity of granzyme B during
host-viral innate immune responses. A web server,
together with reference datasets and supplementary
materials, can be accessed at http://www.casbase.org/
grasvm/index.html.
Results and discussion
Sequence analysis of granzyme B cleavage sites
Using peptide combinatorial libraries, Thornberry and
co-workers had previously identified the presence of dis-
tinctive sequence specificities governing protein cleavage
of both caspase and granzyme B substrates [4]. In parti-
cular, specific tetrapeptide sequences upstream of the
cleavage site (P4-P3-P2-P1) of granzyme B targets serve
as recognition sites for protein cleavage. The tetrapep-
tide “IEPD” was identified as the optimal tetrapetide
cleavage sequence in vitro. However, emerging data on
granzyme B substrates suggest that the in vivo cleavage
specificities are far more diverse, with numerous sub-
strates possessing cleavage specificities extending beyond
the tetrapeptide sequence [5,10].
We compiled a comprehensive dataset of 580 unique
granzyme B cleavage sites extracted from experimentally
verified substrates as reported in literature. Data was
extracted from the substrates list compiled in Barkan et
al. [10], as well as the proteomic studies by Van
Damme et al. [5]. In addition to the P4P1 cleavage site
sequences, segments of different lengths and composi-
tions centered on the P1 position were selected. In all,
eight groups of sequences were obtained - P2P2
’,P 4P1,
P4P2
’,P 4P4
’,P 6P6’,P 8P8
’,P 10P10’ and P14P10’.W ef u r t h e r
extracted an equal number of “non-cleavage” sites by
randomly selecting non-annotated tetrapeptide
sequences (and other corresponding sequence segments)
on the substrates. On the P10P10’ dataset, we computed
Px (or relative position-specific residue propensity) of
each amino acid at the different residue positions along
the 20-mer sequence. Px was computed as the ratio of
the frequency of occurrence of a particular residue in
the cleavage site sequences over the same residue in the
non-cleavage site sequences at the particular position.
As shown in Table 1, measurements of average Px in
the P10P10’ sequences indicate an unusually high enrich-
ment for the negatively charged amino acids Asp and
Table 1 Average Px of amino acids: Average Px of each
amino acid was calculated by averaging the Px values of
the particular amino acid across all residue positions
within the 20-mer sequence window (P10P10
’)
Amino acid Average Px
A 1.14
C 0.72
D 1.98
E 1.46
F 0.80
G 1.02
H 0.48
I 1.05
K 0.69
L 0.88
M 1.10
N 0.86
P 0.93
Q 0.96
R 0.66
S 1.07
T 0.96
V 1.08
W 0.46
Y 0.80
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Conversely, there are significantly lower propensities for
the positively charged amino acids (His, Lys and Arg all
possess average Px of less than 0.70). In addition, the
large hydrophobic residue Trp is also weakly repre-
sented among the cleavage site sequences, with average
Px of 0.46. To further quantify position-specific residue
propensities, we plotted a sequence logo using the
P10P10’ sequences and constructed a heatmap of Px
scores from the same dataset (as shown in Figures 1
and 2 respectively). At P1 position, Asp is expectedly the
most conserved residue, with notable presence of Glu,
Asn and Ser as alternatives. Interestingly, Pro and Cys
residues are more conserved in the cleavage sites com-
pared to the non-cleavage sites at P2 position, while P3
is dominated by the acidic residues Asp and Glu. The
P4 position showed significant propensities for the
branched-chain amino acids Leu, Ile and Val. Remark-
ably, the most prominent feature distinguishing cleavage
site sequences from non-cleavage site sequences appear
to be the extended stretches of acidic residues (Asp and
Glu) upstream and downstream of the cleavage site.
Downstream of the cleavage site, it is further observed
that small amino acids such as Gly, Ser, Ala and Leu are
highly enriched at P1
’ and P2
’. These results indicate that
cleavage sites of granzyme B substrates and the flanking
upstream and downstream sequences have unique posi-
tion-specific residue propensities. These composite sig-
natures could be incorporated into machine learning
algorithms for the development of accurate computa-
tional prediction models.
SVM prediction of granzyme B cleavage sites
To account for these unique signatures of residue con-
servation and position-specific propensities for in silico
prediction, we developed SVM prediction models
incorporating the Bayes Feature Extraction (BFE)
approach as described in Shao et al.[11]. Vector repre-
sentation using the BFE approach was shown to signifi-
cantly improve performance in several bio-
computational problems - such as the prediction of pro-
tein methylation sites [11], caspase cleavage [12] and lin-
ear B-cell epitopes [13] - over simple binary encoding
schemes. In BFE, feature vectors encoded in a bi-profile
manner comprising of positive position-specific and
negative position-specific profiles. These profiles were
generated by accounting for the frequency of occurrence
of each amino acid at each position of the sequences in
the positives pool (cleavage site sequences) and nega-
tives pool (non-cleavage site sequences) respectively.
Here, we trained a series of SVM classifiers on sequence
windows of diverse lengths and compositions (P2P2’,
P4P1,P 4P2 ,P 4P4’,P 6P6’,P 8P8’,P 10P10’ and P14P10’) using
simple binary encoding and BFE schemes (details in
Materials and Methods). Datasets were segmented into
training and independent test sets comprising of 480
positives/480 negatives and 100 positives/100 negatives
respectively. Using the RBF kernel, 10-fold cross-
Figure 1 Sequence logo of amino acids in the vicinity of the
granzyme B cleavage site (P10 to P10
’)
Figure 2 Heat map of relative position-specific amino acid
propensities (Px).P x values were computed for P10P10
’ dataset. Px
values were computed as the ratio of the frequency of occurrence
of the amino acid in the cleavage sites pool over the frequency of
occurrence of the same amino acid in the non-cleavage sites pool
at a specific position. Increasing color intensities (white to blue)
indicate proportionately greater enrichment of the amino acid in
the cleavage sites over non-cleavage sites, and vice versa for
decreasing color intensities.
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of C and g parameter values. SVM classifiers were sub-
sequently trained on the entire training set using the
optimized parameters and evaluated on the independent
test sets.
As given in Table 2, the P4P1 classifier utilizing simple
binary encoding (P4P1-SVM) registered an accuracy of
77.50% and AROC of 0.77 on independent testing. The
other classifiers observed consistent improvement in
accuracy and AROC as the sequence window extends
beyond P4P1 to include the flanking upstream and
downstream residues, achieving the best scores of
83.50% and 0.89 respectively with the P8P8
’-SVM classi-
fier. The P4P1 classifier utilizing BFE scheme (P4P1-
Bayes) attained an accuracy of 76.50% and AROC of 0.84
(Table 3). In a similar fashion, prediction performance
improved steadily as the sequence window is extended
beyond P4P1, achieving the best accuracy of 86.50% with
the P8P8
’-Bayes classifier and the best AROC of 0.94 with
the P10P10
’-Bayes and P14P10
’-Bayes classifiers. Interest-
ingly, in both feature representation schemes, prediction
performances did not significantly improve with
sequences longer than P8P8
’. This could be due to that
fact that much of the information specific for differen-
tiating cleavage sites from non-cleavage sites are
encoded within the sequences situated closer to the
cleavage sites, as evidenced by the unique residue pro-
pensities discussed earlier. In addition, accuracy and
AROC scores across most sequence lengths and composi-
tions were generally higher for classifiers trained using
the BFE scheme, with the greatest improvements
observed when longer sequences (P6P6
’,P 8P8
’,P 10P10
’
and P14P10
’) were employed.
Next, we compared our prediction method with GraB-
Cas [9] and the SVM models developed by Barkan et al.
[10]. As the GraBCas algorithm primarily focuses on the
detection of specific tetrapeptide motifs, we applied the
algorithm on our P4P1 independent test set which con-
tains only the tetrapeptide cleavage site sequences.
Using the recommended cut-off score of 0.12, GraBCas
predicted only 61 out of 100 cleavage sites correctly
(Sn=61%). On the same dataset, our P4P1-SVM and
P4P1-Bayes classifiers respectively predicted 77 out of
100 (Sn=77%) and 79 out of 100 (Sn=79%) cleavage sites
correctly. The weaker sensitivity scores observed for
GraBCas could be due to the utilization of position-spe-
cific scoring matrices (PSSMs) which are derived from a
small, out-dated set of in vitro cleavage specificities and
t h ea b s o l u t er e q u i r e m e n to fA s pr e s i d u ea tP 1 on the
cleavage sites. To further evaluate the performance of
the PSSM-based algorithm in our context, we con-
structed PSSMs derived from our entire dataset of clea-
vage sites, and found that the AROC scores of the PSSM-
based predictors were generally poorer than our SVM-
based classifiers (data not shown). In Barkan et al., the
best SVM classifier recorded a true positive rate (TPR)
of 0.79 and false positive rate (FPR) of 0.21 at the criti-
cal point on the receiver operating characteristic (ROC)
curve when tested on an independent test set. In our
SVM method, several classifiers encoded using the BFE
scheme registered better prediction performance when
measured by the same metrics; P10P10
’-Bayes with TPR
of 0.86 and FPR of 0.14, as well as P14P10
’-Bayes, P8P8
’-
Bayes and P6P6
’-Bayes with TPRs of 0.85 and FPRs of
0.15.
Prediction of granzyme B cleavage of CHIKV proteome
To investigate the applicability of our computational
method, we applied the SVM classifiers on the proteome
of the Chikungunya virus (CHIKV) and analyzed for the
presence of hitherto undiscovered granzyme B cleavage
sites. CHIKV is a member of the alphavirus family and
has been known to be transmitted to humans via the
bite of the virus-borne Aedes mosquito [14]. Acute
infection of CHIKV results in symptoms such as abrupt
fever, skin rash and arthralgia. As CHIKV epidemics
have been re-emerging in recent times, there have been
concerted efforts directed toward developing relevant
vaccines and drug therapies. During viral infections,
granzyme B has been reported to mediate downstream
cleavage of critical host regulatory proteins, leading to
the induction of the apoptotic cell death, and hence
Table 2 Results of SVM prediction using simple binary
encoding
SVM classifier Sensitivity (%) Specificity (%) Accuracy (%) AROC
P2P2
’-SVM 73.00 68.00 70.50 0.77
P4P1-SVM 77.00 78.00 77.50 0.85
P4P2
’-SVM 85.00 76.00 80.50 0.89
P4P4
’-SVM 84.00 80.00 82.00 0.89
P6P6
’-SVM 84.00 82.00 83.00 0.89
P8P8
’-SVM 83.00 84.00 83.50 0.89
P10P10
’-SVM 81.00 82.00 81.50 0.89
P14P10
’-SVM 78.00 81.00 79.50 0.88
Table 3 Results of SVM prediction using Bayes Feature
Extraction
SVM classifier Sensitivity (%) Specificity (%) Accuracy (%) AROC
P2P2
’-Bayes 71.00 71.00 71.00 0.78
P4P1-Bayes 79.00 74.00 76.50 0.84
P4P2
’-Bayes 82.00 80.00 81.00 0.89
P4P4’-Bayes 82.00 81.00 81.50 0.91
P6P6
’-Bayes 86.00 84.00 85.00 0.91
P8P8
’-Bayes 89.00 84.00 86.50 0.93
P10P10
’-Bayes 87.00 85.00 86.00 0.94
P14P10
’-Bayes 88.00 82.00 85.00 0.94
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B-induced apoptotic cell death has long been considered
the de facto mechanism for killing virus-infected cells,
emerging evidence suggest that the enzyme could exert
direct antiviral activity through cleavage of the viral pro-
teins [15]. For these reasons, it is intuitive to speculate if
the CHIKV proteome may be directly regulated by gran-
zyme B activity in this manner and if cleavage of specific
CHIKV proteins will potentiate the host innate immune
responses against viral infectivity.
Four non-structural and four structural proteins of the
CHIKV proteome (strain: LR2006_OPY1) were predicted
for granzyme B cleavage sites using the P8P8’-Bayes clas-
sifier. Since the majority of experimentally verified clea-
vage sites were known to be cleaved after the Asp
residue, we have restricted our prediction scans to only
cleavage sites containing Asp residue at P1.A ss h o w ni n
Table 4, we found potential granzyme B cleavage sites
in all CHIKV proteins except the structural proteins E1,
E3 and 6K. A significantly larger proportion of these
sites were found in the non-structural proteins NSP1,
NSP2, NSP3 and NSP4, as compared to the structural
proteins E2 and capsid. As the alphaviral non-structural
proteins are known to be involved in viral survival and
replication, we would expect the cleavage of these pro-
teins by granzyme B to abrogate viral survival mechan-
isms at different points of the viral reproduction cycle
[16]. Indeed, the cleavage of NSP1 protein at Asp-11
and Asp-58, which are both localized within the methyl-
transferase domain, could lead to inhibition of the
mRNA capping during RNA synthesis. Conversely, the
cleavage of NSP2 helicase do m a i na tA s p - 2 4 7a n dA s p -
343, as well as the RNA polymerase domain at Asp-291,
Asp-371, Asp-476 and Asp-540 on the NSP4 protein
could hinder viral RNA synthesis and translation. In
addition, cleavage of the capsid protein at Asp-112 and
Asp-114 within the protease domain might lead to pre-
vention of auto-cleavage of the immature capsid protein
from the viral structural polyprotein.
Conclusions
In this paper, we constructed a comprehensive database
of experimentally verified granzyme B cleavage sites for
analysis and development of prediction methods. We
discovered that flanking sequences of cleavage sites pos-
sess distinctive residue composition and position-specific
propensity patterns which could be helpful in discrimi-
nating the cleavage sites from non-cleavage sites in
silico. We have rigorously tested SVM classifiers
employing simple binary encoding and the Bayes Fea-
ture Extraction schemes to predict granzyme B cleavage
sites. Results also show that the best classifiers are more
effective than existing algorithms. We applied our pre-
diction method on the Chikungunya viral proteome and
identified several regulatory domains of viral proteins to
be potential targets of granzyme B cleavage, suggesting a
direct antiviral function of granzyme B during host-viral
innate immune responses. To complement experimental
research, we have implemented our prediction method
on a web server which is freely accessible at http://www.
casbase.org/grasvm/index.html. In the immediate future,
we will be exploring the influence of cleavage site sec-
ondary structures, solvent accessibilities and other physi-
cochemical properties on protease-substrate cleavage
specificities, as well as their potential for enhancing the
performance of our SVM prediction models. Computa-
tional prediction of granzyme B substrates will comple-
ment on-going experimental efforts and refine our
understanding of the biochemistry of this fascinating
protease and its relatives.
Materials and methods
Datasets
We extracted a pool of 779 unique, experimentally veri-
fied cleavage sites from literature. 723 sequences were
derived from proteomic experimental studies conducted
by Van Damme et al. [5], with the remaining 56 from
systematic in vitro and in vivo experiments as compiled
in Barkan et al. [10]. We further extracted sequence
Table 4 Prediction of granzyme B cleavage of CHIKV proteome
Protein Biological activity and function Cleavage sites*
NSP1 Non-structural: mRNA capping 9, 11, 58, 525
NSP2 Non-structural: NTPase, helicase and protease activities 116, 247, 343
NSP3 Non-structural: ADP-ribose phosphatase activity 181, 350, 363, 506
NSP4 Non-structural: RNA polymerase activity 219, 371, 476, 540
E1 Structural: virus-host cell fusion Nil
E2 Structural: virus-host cell attachment 77
E3 Structural: unknown Nil
Capsid Structural: protease, viral nucleocapsid formation 112, 174
6K Structural: membrane permeabilization, budding of viral particles Nil
*Position of the P1 residue on the substrate. All predicted cleavage sites contain Asp at P1. Underlines indicate P1 location in the functional domain(s) of protein.
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sites. In all, eight datasets were constructed: the tetra-
peptide cleavage site sequences (referred to as P4P1
dataset) and sequences containing residues extended to
P14 and P10’ (P2P2
’,P 4P2
’,P 4P4
’,P 6P6’,P 8P8
’,P 10P10’ and
P14P10’ datasets). These sequences were assigned as posi-
tive examples for analysis as well as for development of
the SVM method. An equal number of “non-cleavage
sites” or negative examples were obtained by randomly
extracting P1 residues on the substrates. Sequence seg-
ments of the aforementioned lengths and compositions
were obtained as detailed earlier. All datasets of positive
and negative sequences (779/779) were subsequently
subjected to homology filtering using the CD-HIT clus-
tering algorithm [17] where sequences bearing more
than 85% sequence identity with any other sequence in
the dataset were eliminated. The final datasets com-
prised of 580 positive and 580 negative sequences (the
complete list of cleavage sites is available in Additional
File 1). For analysis, all 580 positives and 580 negatives
from the P10P10’ dataset were used. For SVM model
development, datasets were partitioned into training and
test sets consisting of 480 positives/480 negatives and
100 positives/100 negatives respectively.
Sequence analysis
The relative position-specific residue propensity Px was
computed as the ratio of the frequency of occurrence of
a particular amino acid in the cleavage sites pool to its
frequency of occurrence in the non-cleavage sites pool
at a specific position on the sequence. Using the P10P10’
dataset, Px scores were calculated for every amino acid
at each of the twenty residue positions and visualized on
heat maps. Additionally, we constructed a sequence logo
representation of the positive sequences from the P10P10
’
dataset using WebLogo [18].
SVM vector representation
To encapsulate sequence information for SVM training
and testing, input vectors were constructed using simple
binary or bi-profile Bayes Features encoding. For simple
binary encoding, each amino acid is represented by a vec-
tor of 20 dimensions, comprising of binary values of zer-
oes and ones. For example, alanine was represented as
[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1] and cysteine as
[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0]. Hence, in this case,
a 20-mer sequence will be represented by a vector of 400
dimensions (20 x 20). Detailed description on bi-profile
vector encoding using Bayes Features is available in Shao
et al. [11]. In short, feature vectors contain information
from both positive position-specific and negative posi-
tion-specific profiles. These profiles were generated by
accounting for the frequency of occurrence of each
amino acid at each position of the sequences in the
positives pool (cleavage site sequences) and negatives
pool (non-cleavage site sequences) respectively. There-
fore, a 20-mer sequence (from the P10P10’ dataset) would
be represented by a feature vector of 40 dimensions (20 x
2), containing information of the residues in both positive
(cleavage site sequences) and negative (non-cleavage site
sequences) spaces. For all sequence representations, P1
residues were excluded from the feature vectors.
SVM model development
To train and test the SVM models, we used the LIBSVM
package provided by Chang and Lin [19]. For details on
the SVM method, readers are advised to consult the article
by Burges [20]. In short, SVM is grounded on the struc-
tural risk minimization concept from statistical learning
theory. A set of training examples (positives and negatives)
can be encoded by the feature vectors xi (i =1 ,2 , ….N )
with resultant classes yi Î {+1,-1}. The SVM algorithm
trains a classifier by representing the input feature vectors,
using a kernel function in the majority of cases, onto a
high-dimensional space, and then selects a discriminating
hyperplane that separates the two classes with maximal
margin and the least error. The decision function for clas-
sification of unseen examples is defined as:
fx s i g n y Kx x b ii i j
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where K (xi·xj ) is the kernel function, and the para-
meters are resolved by maximizing the following:
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= ∑ 00
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C is the regularization variable that directs the trade-
off between margin and classification error. We used
the radial basis function (RBF) kernel and performed
grid-based optimization for g, which controls the capa-
city of the RBF kernel, and C using 10-fold cross-valida-
tion. In 10-fold cross-validation, the training set was
randomly partitioned into ten subsets where one of the
subsets was used as the test set while the other subsets
were used for training the classifier. The trained classi-
fier was evaluated using the test set. This procedure was
repeated ten times using different subsets for testing,
h e n c em a k i n gs u r et h a ta l ls u b s e t sw e r eu t i l i z e df o r
both training and testing. The optimized g and C values
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generate the SVM classifier for independent testing on
an out-of-sample test set. Graphical plots of optimiza-
tion results are provided in Additional File 2.
Evaluation of model performance
A set of statistical variables were established to evaluate
the performance of the SVM classifier for the prediction
of granzyme B cleavage sites:
(i) True Positives (TP), for the number of correctly
classified cleavage sites.
(ii) False Positives (FP), for the number of incorrectly
classified non-cleavage sites.
(iii) True Negatives (TN), for the number of correctly
classified non-cleavage sites.
(iv) False Negatives (FN), for the number of incor-
rectly classified cleavage sites.
Sensitivity (Sn) and Specificity (Sp), which measures
the capability of the model to correctly classify the clea-
vage sites and non-cleavage sites respectively, were com-
puted as well:
S
TP
TP FN
n =
+
S
TN
TN FP
p =
+
To measure the overall model performance, we com-
puted Accuracy (Acc):
A
TP TN
TP FN TN FP
cc =
+
+++
In addition, we plotted the receiver operating charac-
teristic curve (ROC) and computed the area under the
curve (AROC) for threshold independent evaluation. To
compare against the prediction model developed by Bar-
kan et al., we further determined the critical points on
the ROCs of our SVM classifiers, which are defined as
the points where the ROC curves intersect the lines
connecting coordinates (1, 0) and (0, 1) on the graphs.
Additional material
Additional File 1: Dataset of granzyme B cleavage sites This file
contains the dataset of granzyme B cleavage sites. Training and test set
sequences are listed on different tabs.
Additional File 2: SVM parameter optimization Training sets of
different sequence window datasets were trained under 10-fold cross-
validation using various combinations of C and g values. The optimal C
and g values for each training set are used to train the final SVM
classifier. Optimal values are indicated below the corresponding chart.
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